CY1870A - Derivatives of penciclovir for the treatment of hepatitis-B infections - Google Patents
Derivatives of penciclovir for the treatment of hepatitis-B infectionsInfo
- Publication number
- CY1870A CY1870A CY187096A CY187096A CY1870A CY 1870 A CY1870 A CY 1870A CY 187096 A CY187096 A CY 187096A CY 187096 A CY187096 A CY 187096A CY 1870 A CY1870 A CY 1870A
- Authority
- CY
- Cyprus
- Prior art keywords
- hepatitis
- treatment
- infections
- penciclovir
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898904855A GB8904855D0 (en) | 1989-03-03 | 1989-03-03 | Pharmaceutical treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1870A true CY1870A (en) | 1996-04-05 |
Family
ID=10652653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY187096A CY1870A (en) | 1989-03-03 | 1996-04-05 | Derivatives of penciclovir for the treatment of hepatitis-B infections |
Country Status (18)
Country | Link |
---|---|
US (1) | US6136813A (de) |
EP (1) | EP0388049B1 (de) |
JP (1) | JP2513519B2 (de) |
KR (1) | KR0143410B1 (de) |
AT (1) | ATE122562T1 (de) |
AU (1) | AU628137B2 (de) |
CA (1) | CA2011238C (de) |
CY (1) | CY1870A (de) |
DE (1) | DE69019404T2 (de) |
DK (1) | DK0388049T3 (de) |
ES (1) | ES2072386T3 (de) |
GB (1) | GB8904855D0 (de) |
HK (1) | HK116795A (de) |
HU (1) | HU205715B (de) |
IE (1) | IE67125B1 (de) |
IL (1) | IL93594A (de) |
LV (1) | LV10923B (de) |
ZA (1) | ZA901572B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9326177D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Pharmaceuticals |
US6124304A (en) * | 1993-10-05 | 2000-09-26 | Smithkline Beecham Plc | Penciclovir for the treatment of zoster associated pain |
WO1995022330A1 (en) * | 1994-02-17 | 1995-08-24 | Commonwealth Scientific And Industrial Research Organisation | Antiviral agents |
US7045525B1 (en) | 1995-04-24 | 2006-05-16 | Novartis Ag | Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
AU5127098A (en) * | 1996-11-29 | 1998-06-22 | Smithkline Beecham Plc | Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis |
US5939423A (en) * | 1997-04-16 | 1999-08-17 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir |
AUPO912997A0 (en) * | 1997-09-11 | 1997-10-02 | Commonwealth Scientific And Industrial Research Organisation | Antiviral agents |
US6288033B1 (en) | 1998-09-25 | 2001-09-11 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
ATE457734T1 (de) * | 1998-11-02 | 2010-03-15 | Gilead Sciences Inc | Kombinationstherapie zur behandlung von hepatitis b infektionen |
AU2013257951A1 (en) | 2012-05-11 | 2015-01-22 | Akron Molecules Ag | Use of compounds for the treatment of pain |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
US4230708A (en) * | 1977-10-20 | 1980-10-28 | Stichting Rega V.Z.W. | Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents |
NL8202626A (nl) * | 1982-06-29 | 1984-01-16 | Stichting Rega V Z W | Derivaten van 9-(2-hydroxyethoxymethyl)guanine. |
US4556659A (en) * | 1982-08-09 | 1985-12-03 | Syntex (U.S.A.) Inc. | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents |
US5059604A (en) * | 1982-10-14 | 1991-10-22 | Burroughs Wellcome Co. | 2-amino purine derivatives |
US4649140A (en) * | 1982-10-14 | 1987-03-10 | Burroughs Wellcome Co. | Purine derivatives |
DE3485225D1 (de) * | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
IL73682A (en) * | 1983-12-20 | 1991-08-16 | Medivir Ab | Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation |
EP0182024B1 (de) * | 1984-09-20 | 1991-04-03 | Beecham Group Plc | Purin-Derivate und ihre pharmazeutische Verwendung |
SE8406538D0 (sv) * | 1984-12-21 | 1984-12-21 | Astra Laekemedel Ab | Novel derivatives of purine |
DE3671227D1 (de) * | 1985-07-27 | 1990-06-21 | Beecham Group Plc | 9-substituierte guaninmonohydrate. |
SE8602981D0 (sv) * | 1986-07-04 | 1986-07-04 | Astra Laekemedel Ab | Novel medicinal use |
HU196038B (en) * | 1987-08-07 | 1988-09-28 | Mta Koezponti Kemiai Kutato In | Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine |
SE8801729D0 (sv) * | 1988-05-06 | 1988-05-06 | Astra Ab | Purine derivatives for use in therapy |
GB8823320D0 (en) * | 1988-10-05 | 1988-11-09 | Nycomed As | Chemical compounds |
-
1989
- 1989-03-03 GB GB898904855A patent/GB8904855D0/en active Pending
-
1990
- 1990-03-01 DK DK90302186.3T patent/DK0388049T3/da active
- 1990-03-01 DE DE69019404T patent/DE69019404T2/de not_active Expired - Lifetime
- 1990-03-01 IE IE73390A patent/IE67125B1/en not_active IP Right Cessation
- 1990-03-01 CA CA002011238A patent/CA2011238C/en not_active Expired - Lifetime
- 1990-03-01 HU HU901252A patent/HU205715B/hu unknown
- 1990-03-01 AU AU50600/90A patent/AU628137B2/en not_active Expired
- 1990-03-01 ZA ZA901572A patent/ZA901572B/xx unknown
- 1990-03-01 AT AT90302186T patent/ATE122562T1/de not_active IP Right Cessation
- 1990-03-01 ES ES90302186T patent/ES2072386T3/es not_active Expired - Lifetime
- 1990-03-01 IL IL9359490A patent/IL93594A/en not_active IP Right Cessation
- 1990-03-01 EP EP90302186A patent/EP0388049B1/de not_active Expired - Lifetime
- 1990-03-02 JP JP2049722A patent/JP2513519B2/ja not_active Expired - Lifetime
- 1990-03-03 KR KR1019900002767A patent/KR0143410B1/ko not_active IP Right Cessation
-
1994
- 1994-08-08 US US08/287,476 patent/US6136813A/en not_active Expired - Lifetime
-
1995
- 1995-07-13 HK HK116795A patent/HK116795A/xx not_active IP Right Cessation
- 1995-08-16 LV LVP-95-253A patent/LV10923B/en unknown
-
1996
- 1996-04-05 CY CY187096A patent/CY1870A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HU901252D0 (en) | 1990-05-28 |
GB8904855D0 (en) | 1989-04-12 |
AU628137B2 (en) | 1992-09-10 |
JP2513519B2 (ja) | 1996-07-03 |
HK116795A (en) | 1995-07-21 |
HU205715B (en) | 1992-06-29 |
DK0388049T3 (da) | 1995-06-06 |
ATE122562T1 (de) | 1995-06-15 |
HUT53522A (en) | 1990-11-28 |
IL93594A (en) | 1995-05-26 |
KR0143410B1 (ko) | 1998-07-15 |
JPH02275821A (ja) | 1990-11-09 |
EP0388049B1 (de) | 1995-05-17 |
DE69019404D1 (de) | 1995-06-22 |
IL93594A0 (en) | 1990-12-23 |
US6136813A (en) | 2000-10-24 |
EP0388049A2 (de) | 1990-09-19 |
ZA901572B (en) | 1991-03-27 |
IE900733L (en) | 1990-09-03 |
LV10923A (lv) | 1995-12-20 |
KR900014385A (ko) | 1990-10-23 |
IE67125B1 (en) | 1996-03-06 |
AU5060090A (en) | 1990-11-01 |
DE69019404T2 (de) | 1995-10-12 |
CA2011238C (en) | 2000-03-28 |
EP0388049A3 (de) | 1991-11-06 |
LV10923B (en) | 1996-06-20 |
CA2011238A1 (en) | 1990-09-03 |
ES2072386T3 (es) | 1995-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE02995B1 (et) | 1,3-oksatiolaannukleosiidi analoogide kasutamine hepatiit B ravimpreparaatide valmistamiseks | |
DE19875016I2 (de) | Nukleosidanalogen enthaltende Antiviren-Zubereitungen. | |
HUT61300A (en) | Process for producing pyrazolepyridine derivatives and pharmaceutical compositions comprising same as active ingredient | |
HK116795A (en) | Derivatives of penciclovir for the treatment of hepatitis-B infections | |
DK627987A (da) | Farmaceutiske praeparater | |
DK0855398T3 (da) | Sesquiterpenderivater med antiviral aktivitet | |
DK0728002T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner | |
DK0728001T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 6-infektioner | |
HU904860D0 (en) | Process for the production of medical preparations containing isoflavonic derivatives or salts thereof as active agents |